<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218553</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0029</org_study_id>
    <nct_id>NCT03218553</nct_id>
  </id_info>
  <brief_title>Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery</brief_title>
  <acronym>PACMAN</acronym>
  <official_title>Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery : a Randomized, Multicentre, Double Blind, Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative complications are major healthcare problems and are associated with a reduced
      short-term and long-term survival after surgery. Major surgery is associated with a
      predictable and usually transient Systemic Inflammatory Response (SIRS), depending on the
      magnitude of the surgical trauma. An excessive SIRS syndrome participates to the development
      of postoperative organ dysfunction, infection and mortality. Corticosteroids may decrease the
      postsurgical SIRS in cardiac surgery: in a large multicenter randomized trial, a single
      intravenous administration of high-dose dexamethasone did not reduce the incidence of a
      composite endpoint of adverse events but was associated with a reduced incidence of
      postoperative pulmonary complications and infections and with a reduction in hospital stay.
      However, a similar study, recently published in the Lancet was negative. Evidences from one
      meta-analysis, including 11 studies of moderate quality (439 patients in total), suggest that
      intraoperative administration of corticosteroids during major abdominal surgery decreases
      postoperative complications, including infectious complications, without significant risk of
      anastomotic leakage. At present, no large randomized controlled trial has been performed in
      patients undergoing major non-cardiac surgery. In acute medicine, several lines of evidence
      have shown that low to moderate doses of corticosteroids decrease the excessive inflammatory
      response, without inducing immuno suppression. However, despite the widespread use of
      corticosteroids to reduce postoperative nausea and vomiting and to improve analgesia,
      concerns continue to be raised about their safety, especially regarding an increased risk of
      postoperative infection.

      We hypothesize that the perioperative administration of glucocorticoids would reduce
      postoperative morbidity after major non-cardiac surgery through dampening of the inflammatory
      response. Given the number of surgical patients for whom the question applies, the study is
      of significant clinical importance
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background :

      Postoperative complications are major healthcare problems and are associated with a reduced
      short-term and long-term survival after surgery. Corticosteroids may decrease the
      postsurgical SIRS in cardiac surgery, but this treatment is not recommended yet. The aim of
      the current study is to assess the efficiency and the safety of dexamethasone to prevent on
      postoperative complications.

      Methods :

      The PACMAN trial is a multicenter, randomized, controlled, double-blind, two-arms study. 1022
      patients undergoing major surgery (duration &gt;90 minutes and one or more risk factor of
      postoperative complication) are randomized to dexamethasone (0.2mg/kg at the end of the
      surgery and at day1) or to placebo. The primary outcome is a composite outcome of major
      postoperative complication during 14 days after the surgery.

      Discussion :

      The PACMAN trial is the first randomized controlled trial powered to investigate whether
      perioperative administration of dexamethasone in high risk patients improve outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite outcome at least one item among the following:-Postoperative sepsis, severe sepsis, septic shock-Postoperative pulmonary complication: pneumonia, need for invasive and/or noninvasive ventilation for respiratory failure-All-cause mortality</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital free days</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with post operative sepsis</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative intubation rate for respiratory failure</measure>
    <time_frame>28 days</time_frame>
    <description>Postoperative respiratory failure requiring invasive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with postoperative respiratory failure requiring non-invasive ventilation</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>28 days</time_frame>
    <description>The Clavien-Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned hospitalization in intensive care unit</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients developing postoperative organ failures</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood level of marker of inflammation (C Reactive protein)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed healing defined as non hermetic scar at day 7.</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1222</enrollment>
  <condition>Major Non-cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard cares plus postoperative administrations of glucocorticoid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard cares plus postoperative administrations of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone : first dose : 0,2mg.kg-1 at the end of the surgical procedure, second dose (0,2 mg.kg-1) 24 hours after the surgery</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>placebo : first infusion at the end of the surgical procedure, second 24 hours after the surgery</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Major surgery (&gt; 90 minutes and realized under general anesthesia) of the abdomen, pelvis,
        thorax, face/neck, vascular surgery in a patient older than 65 years Or Major surgery (&gt; 90
        minutes and realized under general anesthesia) of the abdomen, pelvis, thorax, face/neck,
        vascular surgery in a patient older than 50 years and presenting one of the following
        criteria

          -  Presence of a defined risk factor for cardiac or respiratory disease (exercise
             tolerance equivalent to 6 metabolic equivalents or less)

          -  Medical history of stroke

          -  Moderate to severe renal impairment (clearance of creatinine â‰¤ 30 mll/L)

          -  Active smoking

          -  Averaged observed blood losses over 500 ml

          -  Emergency surgery

        Exclusion Criteria:

          -  Pregnant women, Minors, Adults under guardianship or trusteeship

          -  Treatment with systemic corticosteroids at a dose &gt; 5 mg.day-1 of equivalent
             prednisolone in the previous 3 months

          -  Patients with chronic renal failure (clearance of creatinine &lt; 10 ml/min)

          -  Patients for which death is deemed imminent and inevitable or patients with an
             underlying disease process with a life expectancy of less than 1 month

          -  Patient with preoperative shock (defined by the need for vasoactive drugs before
             surgery)

          -  Acute Pulmonary edema in the last 7 days

          -  Active bacterial or viral infection

          -  Allergy to the intravenous formulation of dexamethasone

          -  Uncontrolled psychotic disorder (acute or chronical)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karim ASEHNOUNE, Pr</last_name>
    <phone>+33 2 44 76 68 90</phone>
    <email>karim.asehnoune@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antoine ROQUILLY, Dr</last_name>
    <phone>+33 2 44 78 22 30</phone>
    <email>antoine.roquilly@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sigismond LASOCKI</last_name>
      <email>silasocki@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Jean Verdier</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roland Amathieu</last_name>
      <email>roland.amathieu@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU La Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier Huet</last_name>
      <email>olivier.huet@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Estaing, CHU de Clermont Ferrand</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel FUTIER</last_name>
      <email>efutier@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Etienne BAZIN</last_name>
      <email>jebazin@chu_clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine Paugram</last_name>
      <email>catherine.paugam@bjn.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHD VendÃ©e</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mathieu Oudot</last_name>
      <email>mathieu.oudot@chd-vendee.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Du Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlene Le Moal</last_name>
      <email>charlene.lemoal@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gilles Lebuffe</last_name>
      <email>gilles.lebuffe@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Rimmele</last_name>
      <email>thomas.rimmele@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marion Faucher</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Bruder</last_name>
      <email>nicolas.bruder@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13975</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc Leone</last_name>
      <email>marc.leone@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Saint-Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samir Jaber</last_name>
      <email>s-jaber@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Jules Verne</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florent Capron</last_name>
      <email>florent.capron@mla.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Le Confluent</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jerome Paulus</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>karim ASHENOUNE, Pr</last_name>
      <email>karim.asehnoune@chu-nantes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Antoine ROQUILLY, Dr</last_name>
      <email>antoine.roquilly@chu-nantes.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Laennec</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand Rozec</last_name>
      <email>bertrand.rozec@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>C.R.L.C.C. Nantes Atlantique</name>
      <address>
        <city>Nantes</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frederic Simmoneau</last_name>
      <email>Frederic.simmoneau@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU CarÃ©meau</name>
      <address>
        <city>NÃ®mes</city>
        <zip>30 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe Cuvillon</last_name>
      <email>philippe.cuvillon@chu-nimes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas LESCOT</last_name>
      <email>thomas.lescot@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pitaux Universitaires Saint-Louis, LariboisiÃ¨re, Fernand Widal</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoit Plaud</last_name>
      <email>benoit.plaud@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Lyon Sud</name>
      <address>
        <city>Pierre-BÃ©nite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent Piriou</last_name>
      <email>vincent.piriou@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand Debaene</last_name>
      <email>b.debaene@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Robert DebrÃ©</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benny Charbit</last_name>
      <email>bcharbit@chu-reims.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>HÃ©lÃ¨ne BELOEIL</last_name>
      <email>helene.beloeil@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand Dureuil</last_name>
      <email>bertrand.dureuil@chu-rouen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Saint Etienne</name>
      <address>
        <city>Saint-Ã‰tienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serge Molliex</last_name>
      <email>serge.molliex@chu-st-etienne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nouvel HÃ´pital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julien Pottecher</last_name>
      <email>julien.pottecher@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent Minville</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Pierre-Paul RIQUET</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Geeraerts</last_name>
      <email>geeraerts.t@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cyrus Motamed</last_name>
      <email>Cyrus.MOTAMED@gustaveroussy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>December 6, 2017</last_update_submitted>
  <last_update_submitted_qc>December 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

